A Phase 1b trial shows the higher dose of pociredir boosts fetal hemoglobin levels in adults with sickle cell disease.
The National Coordinator, Association of Persons Living with Sickle Cell Disease, Mrs Aisha Edwards Maduagwu has raised ...
For those willing to take a chance, let's consider two biotech stocks that could eventually become solid, well-established drugmakers: CRISPR Therapeutics ( CRSP 0.76%) and Viking Therapeutics ( VKTX ...
Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...
Recent research from the Medical University of South Carolina laboratory of Russell Norris, Ph.D., challenges the notion that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback